FUKOKU MUTUAL LIFE INSURANCE Co Maintains Stake in UnitedHealth Group Incorporated (UNH)
FUKOKU MUTUAL LIFE INSURANCE Co maintained its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,400 shares of the healthcare conglomerate’s stock at the close of the 2nd quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in UnitedHealth Group were worth $630,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $121,000. Finally, Kings Point Capital Management raised its stake in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares in the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up $3.76 during mid-day trading on Friday, reaching $223.91. 2,233,073 shares of the company traded hands, compared to its average volume of 2,655,638. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Incorporated has a 12 month low of $156.09 and a 12 month high of $231.77. The stock has a market capitalization of $213,340.20, a price-to-earnings ratio of 22.93, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 33.26%.
In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold 62,606 shares of company stock worth $12,677,525 over the last ninety days. Corporate insiders own 0.89% of the company’s stock.
UNH has been the subject of several research analyst reports. Cowen reaffirmed an “outperform” rating and set a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Jefferies Group reaffirmed a “buy” rating and set a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. UBS reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a report on Tuesday, August 29th. Three investment analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $224.56.
TRADEMARK VIOLATION NOTICE: “FUKOKU MUTUAL LIFE INSURANCE Co Maintains Stake in UnitedHealth Group Incorporated (UNH)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/12/09/fukoku-mutual-life-insurance-co-maintains-stake-in-unitedhealth-group-incorporated-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.